Max Robotics — Global Service Robot Directory + US Certification

About

Jay S. Goodman is a leading figure in structural and functional genomics, whose work has revolutionized the production of renewable, high-quality recombinant antibodies. His primary research focuses on developing high-throughput platforms for antibody generation and protein engineering, with a major emphasis on targeting transcription factors—proteins notoriously difficult to work with due to their low abundance and complex folding. Goodman’s most-cited paper (2015, 120 citations) describes an industrialized platform that successfully generated validated recombinant antibodies for 346 transcription factors, addressing a critical bottleneck in biomedical research by replacing traditional, non-renewable commercial sources. This work not only provided a permanent, standardized resource for the scientific community but also demonstrated a scalable method for producing antibodies to folded proteins, significantly advancing reproducibility in cell biology and epigenetics. Beyond this landmark study, Goodman’s contributions have enabled large-scale protein interaction mapping and drug target validation, earning him recognition as a pioneer in antibody engineering. His platform remains a cornerstone for labs seeking reliable reagents, underscoring his lasting impact on molecular tool development and systems biology.